Fibrosing mediastinitis mimicking bronchogenic carcinoma

• Published in: Journal of thoracic disease Vol. 5; no. 1; pp. E5 - E7
• Main Authors: Koksal, Deniz, Bayiz, Hulya, Mutluay, Neslihan, Koyuncu, Adem, Demirag, Funda, Dagli, Gulfidan, Berktas, Bahadir, Berkoglu, Mine
• Format: Journal Article
• Language: English
• Published: China Pioneer Bioscience Publishing Company 01-02-2013
• Subjects: Case Report; bronchogenic carcinoma; tuberculosis; Fibrosing mediastinitis
• ISSN: 2072-1439; 2077-6624
• DOI: 10.3978/j.issn.2072-1439.2012.07.03

Fibrosing mediastinitis is a rare but benign disorder characterized by an excessive fibrotic reaction in the mediastinum which can result in compromise of airways, great vessels, and other mediastinal structures. In this paper we presented a patient with fibrosing mediastinitis mimicking bronchogenic carcinoma. The patient was a 32-year-old diabetic male admitting with cough and hemoptysis. There was a right hilar mass and multiple mediastinal conglomerated lymph nodes on chest computed tomography. Positron emission tomography with computed tomography (PET/CT) scan demonstrated increased fluorodeoxyglucose (FDG) uptake at the right hilar mass lesion and mediastinal lymph nodes. Fiberoptic bronchoscopy showed mucosal distortion of right upper lobe. Pathologic examination of the mucosal biopsy revealed inflammation. Endobronchial ultrasound guided transbronchial needle and cervical mediastinoscopic lymph node biopsies were undiagnostic. Diagnostic thoracotomy confirmed the diagnosis fibrosing mediastinitis. Administration of six months of systemic corticosteroid and antituberculous therapy was not beneficial. In conclusion, despite being a rare clinical entity, fibrosing mediastinitis should be kept in mind in the differential diagnosis of mediastinal mass lesions of unknown etiology. The diagnosis is exceptionally difficult in the presence of atypical radiological findings. The treatment is particularly challenging without any proven effective therapy.